Rugby Miconazole 3 Miconazole nitrate Kit
by Rugby Laboratories · 1 KIT in 1 CARTON (0536-1425-41) * 1 APPLICATOR in 1 POUCH (0113-7198-00) / 5 g in 1 APPLICATOR * 1 TUBE in 1 CARTON (0113-8123-00) / 9 g in 1 TUBE
NDC 00536-1425-41
🏷️ FDA NDC (as labeled)
0536-1425-41
billing pads the labeler segment with a zero
OTC
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
🆔 Identity & classification
FDA NDC (as labeled)
0536-1425-41
Product NDC
0536-1425
11-digit billing NDC
00536142541
NCPDP billing unit
GM — per gram (weight)
Application #
ANDA076357
SPL Set ID
2d7035fa-9695-4d66-89f5-bd26420450ef
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-04-23
Marketing end
2027-06-30
Dosage form
KIT
GPI-14
55104050106464
GCN Seq No
070127
GCN
33451
HICL code
003031
Ingredient (HICL)
Miconazole Nitrate
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q4
Therapeutic class — intermediate (HIC2)
Vaginal Preparations
HIC3 code
Q4F
Therapeutic class — specific (HIC3)
Vaginal Antifungals
AHFS code
84:04.08.08
AHFS class
Azoles (Skin And Mucous Membrane)
FDB label name
MICONAZOLE 3 COMBO PACK
FDB brand name
Miconazole 3
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0536-1425-41 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1425-41. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Azole Antifungal class.
Pharmacologic class
Azole Antifungal
Drug family (ATC)
Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerRugby Laboratories
Application holderL PERRIGO CO
FDA applicationANDA076357 (ANDA)
Labeler code00536
First marketedApr 2024
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name MICONAZOLE 3 COMBO PACK Ingredient Miconazole Nitrate
📖 What it is MedlinePlus · NLM
Vaginal miconazole is used to treat vaginal yeast infections in adults and children 12 years of age and older. Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- For a 7-night vaginal cream, you insert one full applicator into your vagina at bedtime for 7 nights in a row. If you have itching or irritation on the outside, squeeze a small amo...
- I bought a miconazole cream for a vaginal yeast infection — how do I use it correctly?
- Yes — topical miconazole creams and powders are specifically made for those conditions. For athlete's foot and ringworm, you'd apply it to clean, dry skin twice a day for 4 weeks....
- Can I use miconazole cream on my skin for athlete's foot or jock itch?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Miconazole nitrate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
White
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
From the label’s inactive-ingredient sectionPrefilled applicators: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol External cream: benzoic acid, butylated hydroxyanisole, glyceryl stearate, mineral oil, peglicol 5 oleate, pegoxol 7 stearate, purified water
This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.413 | — |
| Medicaid paysCMS SDUD · 12 mo | $0.7060 | — |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per g) — tap or hover for the price & month
Flat over the last 6 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Rugby Miconazole 3this 00536-1425-41 | Rugby | 1 kit | $0.413 | — | Availability likely | — |
| Leader Miconazole 3 70000-0669-01 | Cardinal | 1 kit | $0.413 | — | Availability likely | — |
| foster and thrive miconazole 3 70677-1223-01 | Strategic | 1 kit | $0.413 | — | Availability likely | — |
| Good Neighbor Pharmacy Miconazole 3 24385-0606-02 | Amerisource | 1 suppository | $7.533 | — | Availability likely | +1723% |
| Foster and Thrive Miconazole 3 70677-1226-01 | Strategic | 1 suppository | $7.533 | — | Availability likely | +1723% |
| Good Sense Miconazole 3 00113-0081-00 | L. | 3 suppositories | $7.533 | — | Availability likely | +1723% |
| MICONAZOLE 3 COMBINATION PACK (miconazole nitrate) kit 00713-0593-77 | Cosette | 9 suppositories | $7.533 | — | Availability likely | +1723% |
| Good Neighbor Pharmacy Miconazole 1 46122-0577-02 | Amerisource | 1 suppository | $11.483 | — | Availability likely | +2679% |
| Foster And Thrive Miconazole 1 70677-1294-01 | Strategic | 1 suppository | $11.483 | — | Availability likely | +2679% |
| Miconazole 3 00363-0081-00 | Walgreen | 1 suppository | — | — | Discontinued | — |
| Signature Care Miconazole 1 21130-0040-00 | Safeway | 1 suppository | — | — | FDA listed | — |
| Signature Care Miconazole 3 21130-0102-00 | Safeway | 1 suppository | — | — | FDA listed | — |
| miconazole 3 30142-0081-00 | Kroger | 1 suppository | — | — | FDA listed | — |
| miconazole 1 37808-0199-00 | H | 1 suppository | — | — | FDA listed | — |
| miconazole 3 11822-0209-00 | Rite | 1 suppository | — | — | FDA listed | — |
| careone miconazole 1 41520-0616-00 | American | 1 suppository | — | — | FDA listed | — |
| exchange select miconazole 1 55301-0211-00 | Army | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 Combination Pack 59779-0773-43 | CVS | 3 suppositories | — | — | FDA listed | — |
| Up and Up Miconazole 3 11673-0982-00 | Target | 1 kit | — | — | FDA listed | — |
| Equaline Miconazole 3 41163-0081-00 | United | 1 suppository | — | — | FDA listed | — |
| miconazole 1 41250-0199-00 | Meijer | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 Combination Pack 49035-0345-03 | EQUATE | 3 suppositories | — | — | FDA listed | — |
| Miconazole 3 51316-0689-00 | CVS | 1 suppository | — | — | FDA listed | — |
| miconazole 1 yeast infection relief 59779-0199-00 | CVS | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 59779-0839-00 | CVS | 1 kit | — | — | FDA listed | — |
| Monistat 7 Combination Pack 7-Day Pre-Filled Applicators 63736-0023-15 | Insight | 1 kit | — | — | FDA listed | — |
| Equate Miconazole 3 79903-0241-01 | WALMART | 1 suppository | — | — | FDA listed | — |
| Cvs Miconazole 1 Combination Pack 51316-0093-01 | CVS | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 Combination Pack 59726-0989-03 | P | 3 suppositories | — | — | Discontinued | — |
| Monistat 3 63736-0017-03 | Insight | 3 suppositories | — | — | FDA listed | — |
| Goodnow Miconazole 1 82501-0199-00 | Gobrands, | 1 suppository | — | — | Discontinued | — |
| miconazole 1 11822-1104-00 | Rite | 1 suppository | — | — | Discontinued | — |
| topcare miconazole 1 36800-0199-00 | Topco | 1 suppository | — | — | FDA listed | — |
| Monistat 3 Combination Pack 3 Ovule Inserts 63736-0019-03 | Insight | 3 suppositories | — | — | FDA listed | — |
| miconazole 1 30142-0199-00 | Kroger | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 41250-0982-00 | Meijer | 1 kit | — | — | FDA listed | — |
| CareOne Miconazole 3 41520-0154-00 | American | 1 suppository | — | — | FDA listed | — |
| Vagistat 3 11509-0081-01 | Combe | 1 suppository | — | — | FDA listed | — |
| up and up miconazole 11673-0199-00 | Target | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 21130-0759-00 | Safeway | 1 suppository | — | — | FDA listed | — |
| Basic Care Miconazole 72288-0199-00 | Amazon.com | 1 suppository | — | — | FDA listed | — |
| topcare miconazole 3 combination pack 36800-0081-00 | Topco | 1 suppository | — | — | FDA listed | — |
| dg health miconazole 3 55910-0081-00 | Dolgencorp | 3 suppositories | — | — | FDA listed | — |
| Miconazole 3 Combination Pack 68016-0731-04 | Chain | 3 suppositories | — | — | FDA listed | — |
| Miconazole 1 Walgreens 00363-5211-01 | WALGREEN | 1 suppository | — | — | FDA listed | — |
| Miconazole 3 11822-0800-00 | Rite | 1 kit | — | — | FDA listed | — |
| miconazole 3 37808-0242-00 | H | 1 suppository | — | — | FDA listed | — |
| miconazole 3 41250-0081-00 | Meijer | 1 suppository | — | — | FDA listed | — |
| equate miconazole 1 49035-0199-00 | Wal-Mart | 1 suppository | — | — | FDA listed | — |
| Miconazole 1 Combination Pack 51316-0005-01 | CVS | 1 suppository | — | — | FDA listed | — |
| miconazole 3 day 56062-0081-00 | Publix | 1 suppository | — | — | FDA listed | — |
| Monistat 3 Combination Pack 63736-0010-01 | Insight | 1 kit | — | — | FDA listed | — |
| Monistat 1 Combination Pack 63736-0013-30 | Insight | 1 suppository | — | — | FDA listed | — |
| Miconazole 1 21130-0929-00 | Safeway | 1 suppository | — | — | FDA listed | — |
| Miconazole 1 Walgreens 00363-5201-01 | WALGREEN | 1 suppository | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2024
On the market since
Apr 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1425-41, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
397
Units reimbursed last 4 qtrs
9K
Gross reimbursed last 4 qtrs
$6.3K
Avg / prescription
$15.94
Avg / unit
$0.7060
Latest quarter Q4 2025
112Rx
Medicaid pays / g
$0.7060
gross reimbursed
vs
NADAC / g
$0.4132
acquisition cost
=
Spread
+$0.2928
+71% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 152 Rx Managed care · 245 Rx
State Medicaid map
Units reimbursed · per 100k residents
2.620.4
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Rugby Miconazole 3 (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 24%
Female · 76%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00536-1425-41 You're viewing this | 1 KIT in 1 CARTON (0536-1425-41) * 1 APPLICATOR in 1 POUCH (0113-7198-00) / 5 g in 1 APPLICATOR * 1 TUBE in 1 CARTON (0113-8123-00) / 9 g in 1 TUBE | 2024-04-23 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Kit / multi-component package
Kit / multi-component package
This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | ✓ Available |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0536-1425-41, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00536-1425-41, written without dashes as 00536142541. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00536-1425-41, the first segment (00536) is the labeler code FDA assigned to Rugby Laboratories; the middle segment (1425) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (41) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Rugby Laboratories has reported a marketing end date of 2027-06-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Rugby Laboratories is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses • treats vaginal yeast infections • relieves external itching and irritation due to a vaginal yeast infection
⏱️ Dosage and Administration ▾
Directions • before using this product read the enclosed consumer information leaflet for complete directions and information • adults and children 12 years of age and over: • applicators: insert 1 applicatorful into the vagina at bedtime for 3 nights in a row. Throw applicator away after use. • external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina.
Use 2 times daily for up to 7 days, as needed. • children under 12 years of age: ask a doctor
⚠️ Warnings ▾
Warnings For vaginal use only Do not use if you have never had a vaginal yeast infection diagnosed by a doctor. Ask a doctor before use if you have • vaginal itching and discomfort for the first time • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition. • vaginal yeast infections often (such as once a month or 3 in 6 months).
You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. • been exposed to the human immunodeficiency virus (HIV) that causes AIDS Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur. When using this product • do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs). • do not have vaginal intercourse • mild increase in vaginal burning, itching or irritation may occur • if you do not get complete relief ask a doctor before using another product Stop use and ask a doctor if • symptoms do not get better in 3 days • symptoms last more than 7 days • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).
📦 Storage and Handling ▾
Other information • do not use if printed applicator wrapper is torn, open or incompletely sealed • do not use if seal over tube opening has been punctured • do not purchase if carton is open • store at 20°-25°C (68°-77°F)
🧪 Active Ingredient ▾
Active ingredients Miconazole nitrate 4% Miconazole nitrate 2% (external cream)
🧪 Inactive Ingredients ▾
Inactive ingredients Prefilled applicators: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol External cream: benzoic acid, butylated hydroxyanisole, glyceryl stearate, mineral oil, peglicol 5 oleate, pegoxol 7 stearate, purified water
🎯 Purpose ▾
Purpose Vaginal antifungal
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.